Melyssa M Godfrey

Melyssa M Godfrey,

Clinical Research Coord I

Department: MD-RHEUMATOLOGY
Business Phone: (352) 265-8901

Publications

2023
Efficiency of pain inhibition and facilitation of fibromyalgia patients is not different from healthy controls: Relevance of sensitivity-adjusted test stimuli.
British journal of pain. 17(2):182-194 [DOI] 10.1177/20494637221138318. [PMID] 37057258.
2023
Fibromyalgia is associated with hypersensitivity but not with abnormal pain modulation: evidence from QST trials and spinal fMRI.
Frontiers in pain research (Lausanne, Switzerland). 4 [DOI] 10.3389/fpain.2023.1284103. [PMID] 38116188.
2023
Nociplastic pain: the wolf in sheep’s clothing. Comment on the article by Sunzini et al.
Arthritis & rheumatology (Hoboken, N.J.). [DOI] 10.1002/art.42685. [PMID] 37651266.
2022
Hand size estimates of fibromyalgia patients are associated with clinical and experimental pain.
PloS one. 17(7) [DOI] 10.1371/journal.pone.0270701. [PMID] 35877689.
2021
Fibromyalgia Patients Are Not Only Hypersensitive to Painful Stimuli But Also to Acoustic Stimuli.
The journal of pain. 22(8):914-925 [DOI] 10.1016/j.jpain.2021.02.009. [PMID] 33636370.
2021
Spinal cord neural activity of patients with fibromyalgia and healthy controls during temporal summation of pain: an fMRI study.
Journal of neurophysiology. 126(3):946-956 [DOI] 10.1152/jn.00276.2021. [PMID] 34406893.
2020
Usefulness of Ramp & Hold Procedures for Testing of Pain Facilitation in Human Participants: Comparisons With Temporal Summation of Second Pain.
The journal of pain. 21(3-4):390-398 [DOI] 10.1016/j.jpain.2019.08.004. [PMID] 31425887.

Grants

Jul 2023 ACTIVE
A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab administered subcutaneously versus placebo, in combination with a glucocorticoid taper regimen, in patients with polymyalgia rheumatica (PMR)
Role: Other
Funding: NOVARTIS PHARMACEUTICALS CORP
Nov 2020 ACTIVE
Biomarker evaluation for the differential diagnosis and monitoring of fibromyalgia compared to autoimmune rheumatic diseases, other pain syndromes, and normal subjects
Role: Other
Funding: EXAGEN

Contact Details

Phones:
Business:
(352) 265-8901
Addresses:
Business Mailing:
PO Box 100221
GAINESVILLE FL 32610
Business Street:
BOX 100221
1600 SW ARCHER RD
GAINESVILLE FL 32610